Desq Long
Sign in
SEC FORM 4
$167,403.60

REGENERON PHARMACEUTICALS, INC. (REGN)

Sale of 219 shares at $764.4 per share.

Reporting Person MURPHY ANDREW J · Officer Title Co-Chief Scientific Officer · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001796226-26-000002 · filed 2026-10-15 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "REGENERON PHARMACEUTICALS, INC. (REGN)." Disclosed 2026-10-15. https://desqlong.com/cards/0001796226-26-000002-12 (retrieved 2026-10-16).